204 related articles for article (PubMed ID: 11874898)
21. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
[TBL] [Abstract][Full Text] [Related]
22. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.
Granoff DM
Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B117-25. PubMed ID: 19477054
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
24. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
Vu DM; Welsch JA; Zuno-Mitchell P; Dela Cruz JV; Granoff DM
J Infect Dis; 2006 Mar; 193(6):821-8. PubMed ID: 16479517
[TBL] [Abstract][Full Text] [Related]
25. Serum bactericidal antibody assays - The role of complement in infection and immunity.
McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
[TBL] [Abstract][Full Text] [Related]
26. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
[TBL] [Abstract][Full Text] [Related]
27. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.
Hankins WA; Gwaltney JM; Hendley JO; Farquhar JD; Samuelson JS
Proc Soc Exp Biol Med; 1982 Jan; 169(1):54-7. PubMed ID: 6801667
[No Abstract] [Full Text] [Related]
28. Meningococcal surrogates of protection--serum bactericidal antibody activity.
Borrow R; Balmer P; Miller E
Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.
Trotter CL; Findlow H; Borrow R
Clin Vaccine Immunol; 2012 Feb; 19(2):219-22. PubMed ID: 22190393
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
31. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
[TBL] [Abstract][Full Text] [Related]
32. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
33. A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.
Block SL; Szenborn L; Daly W; Jackowska T; D'Agostino D; Han L; Dull PM; Smolenov I
Vaccine; 2015 May; 33(21):2500-10. PubMed ID: 25795256
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
35. Assay parameters and methods of data analysis for the comparison of complement sources in the Neisseria meningitidis serogroup C serum bactericidal assay.
Jodar L; Stephens D; Feavers IM
Biologicals; 2002 Dec; 30(4):323-9. PubMed ID: 12474864
[No Abstract] [Full Text] [Related]
36. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
[TBL] [Abstract][Full Text] [Related]
37. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.
Fusco PC; Farley EK; Huang CH; Moore S; Michon F
Clin Vaccine Immunol; 2007 May; 14(5):577-84. PubMed ID: 17376859
[TBL] [Abstract][Full Text] [Related]
38. Humoral immune responses to Neisseria meningitidis in children.
Pollard AJ; Galassini R; van der Voort EM; Booy R; Langford P; Nadel S; Ison C; Kroll JS; Poolman J; Levin M
Infect Immun; 1999 May; 67(5):2441-51. PubMed ID: 10225907
[TBL] [Abstract][Full Text] [Related]
39. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.
Memish ZA; Yezli S; Almasri M; Assiri A; Turkestani A; Findlow H; Bai X; Borrow R
Int J Infect Dis; 2014 Nov; 28():171-5. PubMed ID: 25307887
[TBL] [Abstract][Full Text] [Related]
40. Construction and protective immunogenicity of DNA vaccine pNMB0315 against Neisseria meningitidis serogroup B.
Wu X; Li K; Xie M; Yu M; Tang S; Li Z; Hu S
Mol Med Rep; 2018 Feb; 17(2):3178-3185. PubMed ID: 29257302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
